Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy

Yusoh, NA; Ahmad, H; Gill, MR

CHEMMEDCHEM, 2020; 15 (22): 2121

Abstract

Platinum drugs are heavily used first-line chemotherapeutic agents for many solid tumours and have stimulated substantial interest in the biological a......

Full Text Link